Down-regulation of Th1 responses in human neonates

Por MARÓDI, L
Publicado em 2002

Stimulation of the respiratory burst and promotion of bacterial killing in human granulocytes by intravenous immunoglobulin preparations.

Por Maródi, L, Kalmár, A, Karmazsin, L
Publicado em 1990

Opsonic activity in serum from septic infants treated with intravenous immunoglobulin.

Por Maródi, L, Kalmár, A, Szabó, I
Publicado em 1989

Cytokine receptor signalling in neonatal macrophages: defective STAT-1 phosphorylation in response to stimulation with IFN-γ

Por Maródi, L, Goda, K, Palicz, A, Szabó, G
Publicado em 2001

A multi-centre study of efficacy and safety of Intratect®, a novel intravenous immunoglobulin preparation

Por Kreuz, W, Erdös, M, Rossi, P, Bernatowska, E, Espanol, T, Maródi, L
Publicado em 2010

Enhancement of macrophage candidacidal activity by interferon-gamma. Increased phagocytosis, killing, and calcium signal mediated by a decreased number of mannose receptors.

Por Maródi, L, Schreiber, S, Anderson, D C, MacDermott, R P, Korchak, H M, Johnston, R B
Publicado em 1993

Efficacy, safety, tolerability and pharmacokinetics of a novel human immune globulin subcutaneous, 20%: a Phase 2/3 study in Europe in patients with primary immunodeficiencies

Por Borte, M., Kriván, G., Derfalvi, B., Maródi, L., Harrer, T., Jolles, S., Bourgeois, C., Engl, W., Leibl, H., McCoy, B., Gelmont, D., Yel, L.
Publicado no Clin Exp Immunol (2016)